Lab Automation’s Cogent Trichotomy

Lab Automation Unconstrained by a Strict Definition What is lab automation? Lab automation involves controlling tools and equipment with minimal interaction. It integrates automated technologies into the laboratory to streamline processes and eliminate repetitive tasks, improving throughput and quality. It is essential for labs to remain competitive and meet demands, especially as they face challenges […]

a screenshot with the words directed evolution

Using Directed Evolution to Spur Innovation and Discovery

The Power of Technology in Bioengineering  Technology plays a critical role in the success of bioengineering, an ever-evolving field in which scientists spend their time researching new ways to improve biology by leveraging principles of engineering.  In some instances, bioengineering efforts can be lifesaving. This includes improving current medical procedures and propelling pharmaceutical research.  But […]

an image of an automated lab

What to Know When Automating Your Lab

The modern laboratory can be a complicated environment.  Laboratories are filled with highly specialized and expensive pieces of equipment.  Researchers perform workflows and processes that not only have many different steps but must also be performed with a high degree of precision to guarantee accurate results. Naturally, before automating such a complex environment, it is […]

HRB & TETRASCIENCE

Cloud-based Data Management with Lab Automation: HighRes Biosolutions Cellario + TetraScience

Integration between HighRes Biosolutions’ Cellario lab automation software and the TetraScience Platform provides cloud-based data management and unlocks data science   Authors: Kai Wang, Delivery Team Lead, TetraScience Spin Wang, CEO and Co-Founder, TetraScience Ira Hoffman, CEO, HighRes Biosolutions HighRes Biosolutions Cellario lab automation system with the TetraScience Data Integration Platform to optimize data management […]

Machine Learning and Drug Discovery

Yesterday, Recursion Pharmaceuticals announced that the Food and Drug Administration had cleared their investigational new drug application for a Phase 1 clinical trial in the treatment of cerebral cavernous malformation (CCM). While this is certainly good news for treating this rare genetic disease, it is also an important milestone in the use of machine learning […]

Request Info